Summary
Emily Olafson is a Principal Scientist and imaging expert with eight years of experience translating advanced neuroimaging into actionable biomarkers for clinical trials and decision-making. Currently at Regeneron after a postdoc at Genentech, she has led development of harmonized tau PET quantification and scalable preprocessing pipelines that supported patient stratification and early-stage Alzheimer's studies. Trained as a neuroscientist (PhD candidate at Weill Cornell) with hands-on software skills in MATLAB and Python, she combines rigorous algorithm development with statistical analysis of large clinical datasets. Beyond industry impact, she has taught neuropsychopharmacology in prison education programs and built novel outlier-replacement and biomarker extraction pipelines during her academic work—showing a rare mix of technical depth, translational focus, and commitment to broader scientific communication.
8 years of coding experience
1 year of employment as a software developer
Bachelor of Science - BS, Neuroscience, Bachelor of Science - BS, Neuroscience at McGill University
William Lyon Mackenzie Collegiate Institute
Doctor of Philosophy - PhD, Neuroscience, Doctor of Philosophy - PhD, Neuroscience at Weill Cornell Graduate School of Medical Sciences
French